Overview

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Status:
Recruiting
Trial end date:
2028-03-31
Target enrollment:
Participant gender:
Summary
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.
Phase:
Phase 4
Details
Lead Sponsor:
GW Research Ltd
Treatments:
Cannabidiol
Epidiolex